In Vivo Skin Permeation of Sodium Naproxen Formulated in Pluronic F-127 Gels: Effect of Azone® and Transcutol®

References

• Afouna, M. I., Fincher, T. K., Zaghloul, A. A. A., & Reddy, I. K. (2003). Effect of Azone upon the in vivo antitumoral efficacy of cidofovir or acyclovir topical formulations in treatmeny/preventation of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice. International Journal of Pharmaceutics, 253, 159–168., [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Barthélémy, P., Farah, N., & Laforet, J. P. (1995). Transcutol-product profile. Gattefossé, Technical bulletin, 1–10., [CSA]
   Google Scholar
• BASF Wyandotte Corp; Industrial Chemical Group (1973a). The Wonderful World of Pluronic Polyols. Catalog Card No. 70-150738, BASF Corp.
   Google Scholar
• BASF Wyandotte Corp; Industrial Chemical Group (1973b). Pluronic Polyols, Toxicity and Irritation Data. Publication No. OS-3012, BASF Corp.
   Google Scholar
• Casal, H. L., & Mantsch, H. H. (1984). Polymorphic phase behaviour of phospholipids membranes studied by infrared spectroscopy. Biochimica et Biophysica Acta, 779, 381–401., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Degim, L. T., Uslu, A., Hadgraft, J., Atay, T., Akay, C., & Cevheroglu, S. (1999). The effects of Azone and capsaicin on the permeation of naproxen through human skin. International Journal of Pharmaceutics, 179, 21–25., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• DiBiase, M. D., & Rhodes, C. T. (1991). Investigations of epidermal growth factor in semisolid formulations. Pharmaceutica Acta Helvetiae, 66, 165–169., [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• DiBiase, M., & Rhodes, C. (1996). Formulation and evaluation of epidermal growth factor in Pluronic-127 gel. Drug Development and Industrial Pharmacy, 22(8), 823–831.
   Web of Science ®Google Scholar
• Fang, J.-Y., Leu, Y.-L., Hwang, T.-L., Cheng, H.-Ch., & Hung, Ch.-F. (2003). Development of sesquiterpenes from Alpnia oxyphylla as novel skin permeation enhancers. European Journal of Pharmaceutical Sciences, 19, 253–262., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ganem-Quintanar, A., Lafforgue, A. C., Falson-Rieg, F., & Buri, P. (1997). Evaluation of the transepidermal permeation of diethyleneglycol monoethylether and skin water loss. International Journal of Pharmaceutics, 147, 165–172., [CROSSREF]
   Web of Science ®Google Scholar
• Gilbert, J. C., Hadgraft, J., Bye, A., & Brookes, L. (1986). Drug release from Pluronic F-127 gels. International Journal of Pharmaceutics, 32, 223–228., [CROSSREF]
   Web of Science ®Google Scholar
• Godwin, D. A., Kim, N. H., & Felton, L. A. (2002). Influence of Transcutol CG on the skin accumulation and transepidermal permeation of ultraviolet absorbers. European Journal of Pharmaceutics and Biopharmaceutics, 53, 23–27., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hadgraft, J., Walters, K. A., & Wotton, P. K. (1985). Facilitated transport of sodium salicylate across an artificial lipid membrane by azone. Journal of Pharmacy and Pharmacology, 37, 725–727., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hadgraft, J., Peck, J., Williams, G. D., Pugh, J. W., & Allan, G. (1996). Mechanisms of action of skin penetration enhancers/retarders: Azone and analogues. International Journal of Pharmaceutics, 141, 17–25., [CROSSREF]
   Web of Science ®Google Scholar
• Harrison, J. E., Watkinson, A. C., Green, D. M., Hadgraft, J., & Brain, K. (1996). The relative effect of Azone and Transcutol on permeant diffusivity and solubility in human stratum corneum. Pharmaceutical Research, 13, 542–546., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jain, N. K., Shah, B. L., & Taneja, L. N. (1991). Nasal absorption of metoprolol tartrate. Indian Journal of Pharmaceutical Sciences, 53, 16–19.
   Google Scholar
• Koller, C., & Buri, P. (1987). Propriétés e intérêt pharmaceutique des gels thermoréversibles à base de poloxamers et poloxamines. STP Pharmaceutics, 3(2), 115–124.
   Google Scholar
• Lee, T. W., Kim, J. Ch. ., & Hwangl, S. J. (2003). Hydrogel patches containing Triclosan for acne treatment. European Journal of Pharmaceutics and Biopharmaceutics, 56, 407–412., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Li, H., & Sung, K. C. (2000). Carbopol/pluronic phase change solutions for ophthalmic drug delivery. Journal of Controlled Release, 69, 379–388., [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• López, A., Llinares, I., Cortell, C., & Herráez, M. (2000). Comparative enhancer effects of Span®20 with Teewn®20 and Azone on the in vitro percutaneous penetration of compounds with different lipophilicities. International Journal of Pharmaceutics, 202, 133–140., [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Miyazaki, S., Takeuchi, S., Yokouchi, C., & Takada, M. (1984). Pluronic F-127 gels as vehicles for topical administration of anticancer agents. Chemical and Pharmaceutical Bulletin, 32(10), 4205–4208.
   PubMed Web of Science ®Google Scholar
• Mura, P., Faucci, M. T., Bramanti, G., & Corti, P. (2000). Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. European Journal of Pharmaceutical Sciences, 9, 365–372., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Naik, A., & Guy, R. H. (1997). Mechanisms of Transdermal Drug Delivery: Infrared Spectroscopy and Differential Scanning Calorimetric Investigations of the Stratum Corneum Barrier Function (pp. 87–162). New York: Marcel Dekker, Inc.
   Google Scholar
• Pu, Y., & Lyn, P. (1998). Water permeation barrier in isolated cutaneous newborn rat epidermis. Journal of Pharmacological and Toxicological Methods, 40, 145–149., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ritschel, W. A., Panchagnula, R., Stemmer, K., & Ashraf, M. (1991). Development of an intracutaneous depot for drugs. Binding, drug accumulation and retention studies, and mechanisms of depot. Skin Pharmacology, 4, 235–245., [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Ryu, J. M., Chung, S.-J., Lee, M.-H., Chang-Kook, K., & Chang-Koo, S. (1999). Increased bioavailability of propanolol in rats by retaining thermally gelling liquid suppositories in the rectum. Journal of Controlled Release, 59, 163–172., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schmolka, I. R. (1972). Artificial skin I. Preparation and properties of Pluronic F-127 gels for treatment of burns. Journal of Biomedical Materials Research, 6, 571–582., [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schmolka, I. R. (1974). Pluronic® polyols in skin lotions. Cosmética & Perfumaria, 89, 63–66.
   Google Scholar
• Shing, P., & Roberts, M. S. (1994). Skin permeability and local tissue concentration of nonsteroidal anti-inflammatory drugs after topical application. Journal of Pharmacology and Experimental Therapeutics, 268, 144–151.
   PubMed Web of Science ®Google Scholar
• Suh, H., Jun, H. W., Dzimianski, M. T., & Lu, G. W. (1997). Pharmacokinetic and local tissue disposition studies of naproxen following topical and systemic administration in dogs and rats. Biopharmaceutics & Drug Disposition, 18(7), 623–633., [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Takeuchi, Y., Yasukawa, H., Yamaoka, Y., Taguchi, K., Fukushima, S., Shimouaka, Y., Nishinaga, H., & Morimoto, Y. (1995). Behaviour of propylene glycol in dermis after treatment of rat intact skin surface with fatty acids, fatty amines or Azone dissolved in propylene glycol. Biological & Pharmaceutical Bulletin, 18, 304–309., [CSA]
   PubMed Web of Science ®Google Scholar
• Tanojo, H., Junginger, H. E., & Boddé, H. E. (1997). In vivo human skin permeability enhancement by oleic acid: transepidermal water loss and Fourier-transform infrared spectroscopy studies. Journal of Controlled Release, 47, 31–39., [CROSSREF]
   Web of Science ®Google Scholar
• Touitou, E., Levy-Schaffer, F., Dayan, N., Alhaique, F., & Riccieri, F. (1994). Modulation of caffeine skin delivery by carrier design: liposomes versus permeation enhancers. International Journal of Pharmaceutics, 103, 31–136.
   Google Scholar
• Valjakka-Koskela, R., Kirjavainen, M., Mönkkönen, J., Urtti, A., & Kiesvaara, J. (1998). Enhancement of percutaneous absorption of naproxen by phospholipids. International Journal of Pharmaceutics, 175, 225–230., [CROSSREF]
   Web of Science ®Google Scholar
• Van den Ouweland, F. A., Eenhoorn, P. C., Tan, Y., & Gribnau, F.W.J. (1989). Transcutaneous absorption of naproxen gel. European Journal of Clinical Pharmacology, 36, 209–211., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Watkinson, A. C., Hadgraft, J., & Bye, A. (1991). Aspects of the transdermal delivery of prostaglandins. International Journal of Pharmaceutics, 74, 229–236., [CROSSREF]
   Web of Science ®Google Scholar
• Williams, A. C., & Barry, B. W. (2004). Penetration enhancers. Advanced Drug Delivery Reviews, 56, 603–618., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar